Ferric citrate
Composition
This Formulation contains Ferric citrate as active ingrediant.
Indications
Used in patients patients with chronic kidney disease (CKD) on dialysis.
Side effects
Common side effects may include diarrhea, nausea, constipation, dark-colored stools, and abdominal pain.
Precautions
Use with caution in patients with gastrointestinal disorders.
Contraindications
Contraindicated in patients with hemochromatosis.
Dosage and administration
1 gm of tablet thrice in a day, as prescribed by healthcare provider
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai